MV Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $87.3K | Sell |
196
-210
| -52% | -$93.5K | 0.01% | 251 |
|
|
2025
Q1 | $197K | Buy |
406
+210
| +107% | +$102K | 0.02% | 177 |
|
|
2024
Q4 | $78.9K | Buy |
196
+4
| +2% | +$1.61K | 0.01% | 252 |
|
|
2024
Q3 | $89.3K | Hold |
192
| – | – | 0.01% | 246 |
|
|
2024
Q2 | $90K | Buy |
192
+9
| +5% | +$4.22K | 0.01% | 241 |
|
|
2024
Q1 | $76.5K | Sell |
183
-12
| -6% | -$5.02K | 0.01% | 258 |
|
|
2023
Q4 | $79.3K | Buy |
195
+16
| +9% | +$6.51K | 0.01% | 246 |
|
|
2023
Q3 | $62.2K | Buy |
179
+11
| +7% | +$3.83K | 0.01% | 266 |
|
|
2023
Q2 | $59.1K | Buy |
168
+10
| +6% | +$3.52K | 0.01% | 274 |
|
|
2023
Q1 | $49.8K | Buy |
158
+11
| +7% | +$3.47K | 0.01% | 282 |
|
|
2022
Q4 | $42.5K | Buy |
147
+1
| +0.7% | +$289 | 0.01% | 245 |
|
|
2022
Q3 | $42K | Buy |
146
+24
| +20% | +$6.9K | 0.01% | 235 |
|
|
2022
Q2 | $34K | Sell |
122
-1
| -0.8% | -$279 | 0.01% | 258 |
|
|
2022
Q1 | $32K | Buy |
123
+31
| +34% | +$8.07K | ﹤0.01% | 270 |
|
|
2021
Q4 | $20K | Buy |
92
+6
| +7% | +$1.3K | ﹤0.01% | 327 |
|
|
2021
Q3 | $16K | Buy |
86
+76
| +760% | +$14.1K | ﹤0.01% | 348 |
|
|
2021
Q2 | $2K | Buy |
10
+3
| +43% | +$600 | ﹤0.01% | 639 |
|
|
2021
Q1 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 318 |
|